Jed Zobitz is a partner in Cravath’s Corporate Department. He works in all areas of the Firm’s corporate practice. Currently, his practice focuses on complex syndicated loan transactions, primarily in the context of acquisition financings and leveraged recapitalizations, mergers and acquisitions and general corporate representations.
Mr. Zobitz has been involved in a variety of notable representations recently, including representing UAL Corporation in connection with its merger with Continental Airlines, the sale of Millipore to Merck KGaA, the sale of Burlington Northern Santa Fe to Berkshire Hathaway, and the purchase by Johnson & Johnson of approximately 18% of the stock of Elan Corporation and its acquisition of Elan’s rights in Elan’s Alzheimer’s Immunotherapy Program. He has also represented Brink’s in connection with its spin-off of its Brink’s Home Security Business, Qualcomm in connection with the settlement of its patent litigation with Broadcom and IBM in connection with several divestitures and acquisitions.
Mr. Zobitz has been repeatedly recognized as one of the country’s leading practitioners in banking and finance by, among others, Chambers Global: The World’s Leading Lawyers for Business in 2012; Chambers USA: America’s Leading Lawyers for Business from 2007 through 2011; and PLC Which Lawyer? Mr. Zobitz was also recognized for his transactional work in the technology industry by The Legal 500 in 2010 and 2011.
Mr. Zobitz was born in New York, New York. He received a B.A. from Franklin & Marshall College in 1991 and a J.D. cum laude from New York University in 1995. He joined Cravath in 1995 and became a partner in 2003.
Mr. Zobitz may be reached by phone at 212-474-1996 or by email at jzobitz@cravath.com.